A Review of Research Progress on Glycemic Variability and Gestational Diabetes
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Gestational diabetes mellitus (GDM) is associated with many adverse obstetric outcomes and neonatal outcomes, including preeclampsia, Cesarean section, and macrosomia. Active screening and early diabetes control can reduce the occurrence of adverse outcomes. Glycosylated hemoglobin (HbA1c) only reflects average blood glucose levels, but not glycemic variability (GV). Studies have shown that GV can cause a series of adverse reactions, and good control of GV can reduce the incidence of adverse pregnancy outcomes in patients with GDM. In order to provide clinicians with a better basis for diagnosis and treatment, this study reviewed the measurement, evaluation, and control of GV, the importance of GV for patients with GDM, and correlations between GV and maternal and neonatal outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability
Service, F. J., Molnar, G. D., Rosevear, J. W., Ackerman, E., Gatewood, L. C., & Taylor, W. F. (1970) · Diabetes · doi:10.2337/diab.19.9.644 · Cited by 1,039
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.012 · Cited by 914
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Research works printed but not linked: 6
- 6. Society. CD. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition). Chin J Pract Intern Med. 2018;38 (4):292-344.
- 7. gynecology Csooa. Guidelines for the diagnosis and treatment of gestational diabetes mellitus. Diabetes World. 2014;8(11):489-498.
- 37. Dovepress Yu et al Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020:13 submit your manuscript | www.dovepress.com DovePress
- 43. endocrinology Cso. Experts consensus on management of glycemic variability of diabetes mellitus. Drug Evaluation. 2017;014(17):5-8,14.
- 52. Costabile L, Unfer V. Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case. Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):73-76.
- 60. Administration UFaD. FDA authorizes first fully interoperable con- tinuous glucose monitoring system, streamlines review pathway for similar devices. Fda News Release. 2018.
Cited by
Sanusi, A. A., Xue, Y., McIlwraith, C. A., Howard, H., Brocato, B. E., Casey, B. M., Szychowski, J. M., & Battarbee, A. N. (2023) · Diabetes Care · doi:10.2337/dc23-0636 · Cited by 69
Shi, P., Liu, A., & Yin, X. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03982-4 · Cited by 49
Shi, P., Tang, J., & Yin, X. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05630-5 · Cited by 39
“Women with GDM have an increased risk of hypertension, hyperbilirubinemia, coronary heart disease, preeclampsia, and cesarean section and have a higher risk of long-term obesity and diabetes post-pregnancy [9, 10].”
BackgroundA new continuous glucose monitor for the diagnosis of gestational diabetes mellitus: a pilot study
Filippo, D. D., Henry, A., Bell, C., Haynes, S., Chang, M. H. Y., Darling, J., & Welsh, A. W. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05496-7 · Cited by 34
Research Progress on the Experimental Animal Model of Gestational Diabetes Mellitus
He, Y., Wu, N., Yu, W., Li, L., Ouyang, H., Liu, X., Qian, M., & Al-Mureish, A. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s270935 · Cited by 34
Self-citationProgress in Research on Biomarkers of Gestational Diabetes Mellitus and Preeclampsia
Liu, Y., Li, D., Bolatai, A., & Wu, N. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s433179 · Cited by 26
Self-citationGáborová, M., Doničová, V., Bačová, I., Pallayová, M., Bona, M., Peregrim, I., Gresova, S., Stimmelova, J., Dzugasová, B., Blichová, L. Š., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073402 · Cited by 22
“It does not reflect the acute changes of blood glucose, the range of glucose changes during day, and it can ́t reflect blood GV [23].”
BackgroundKytö, M., Koivusalo, S. B., Tuomonen, H., Strömberg, L., Ruonala, A., Marttinen, P., Heinonen, S. T., & Jacucci, G. (2023) · JMIR Diabetes · doi:10.2196/43979 · Cited by 23
Glycemic Variability in Early Pregnancy May Predict a Subsequent Diagnosis of Gestational Diabetes
Quah, P. L., Tan, L. K., Lek, N., Thain, S. P. T., & Tan, K. H. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s379616 · Cited by 16
“We chose to include a range of GV and GC parameters that are clinically relevant9 and suitable for GDM pregnant women,2 which include mean amplitude of glycemic excursion (MAGE), standard deviation (SD), mean glucose, and percentage coefficient of variation (%CV), used commonly in available studies as measures of GV.1…”
InfluentialTiselko, A. V., Kapustin, R. V., Milyutina, Y. P., Borovik, N. V., Ивановна, А. Е., & Yarmolinskaya, M. I. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2050361 · Cited by 14
“But a majority of them are devoted to gestational diabetes [20,21].”
BackgroundScreening and management of major endocrinopathies during pregnancy: an update
Paschou, S. Α., Bletsa, E., Papazisi, M., Mili, N., Kanouta, F., Kassi, G., Ψαλτοπούλου, Θ., Goulis, D. G., & Lambrinoudaki, I. V. (2022) · Endocrine · doi:10.1007/s12020-022-03237-y · Cited by 14
Ku, C. W., Zheng, R. T., Tan, H. Y., Lim, J., Chen, L., Cheung, Y. B., Godfrey, K. M., Chan, J. K. Y., Yap, F. K. P., Lek, N., et al. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01508-4 · Cited by 13
“Monitoring glycemic variability is especially important in pregnancy due to the established association of poorer glycemic variability with poorer pregnancy outcomes [46].”
Quah, P. L., Tan, L. K., Lek, N., Tagore, S., Chern, B. S. M., Ang, S. B., Wright, A., Thain, S. P. T., & Tan, K. H. (2024) · American Journal of Perinatology · doi:10.1055/s-0043-1778664 · Cited by 10
“1,8,19 Moreover, better glycemic control has overall led to improved obstetric and neonatal outcomes, in studies involving pregnant women with type 1 diabetes, 20 type 2 diabetes, 17 and gestational diabetes.”
BackgroundBlasi, I., Daolio, J., Pugni, V., Comitini, G., Morciano, M., Grassi, G., Todros, T., Gargano, G., & Aguzzoli, L. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282895 · Cited by 8
RetractedCosson, E., Tatulashvili, S., Vicaut, É., Pinto, S., Sal, M., Nachtergaele, C., Berkane, N., Benbara, A., Fermaut, M., Portal, J.-J., et al. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101469 · Cited by 7
van Heerden, A. C., Kolozali, Ş., & Norris, S. A. (2022) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2022.2114408 · Cited by 6
“Although there is currently mixed evidence as to the clinical outcomes value of CGM in pregnancy, 21 our data suggest another benefit.”
BackgroundYu, W., Liu, X., & Wu, N. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-6476 · Cited by 7
“We have previously reviewed the importance of GV in patients with GDM and their related progress and found that well-controlled GV has greater benefits for patients with GDM (7).”
Self-citationFilippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. W. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04629-8 · Cited by 6
“A recent review concluded that the use of CGM may help understanding glycaemic patterns and that the glycaemic variability within a day and within consecutive days can predict pregnancy outcomes [38].”
BackgroundMethodInfluentialZhang, R., Gao, X., Sun, T., Li, H., Yang, Q., Li, B., Zhu, D., & Wang, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1054153 · Cited by 7
“GDM may cause serious complications during pregnancy (12, 13), including gestational hypertension, high infection risk, macrosomia, neonatal unit care admission, abortion, and premature birth (14).”
BackgroundLiang, G., Lai, M., Wang, Y., Li, N., Kang, M., Lu, J., Su, Y., Fang, F., Peng, Y., Xu, X., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15698 · Cited by 5
“13 Although GDM presents as mild hyperglycaemia during pregnancy, glucose levels and variability are closely associated with pregnancy outcomes in women with GDM. 14,15 Conventional CGM metrics include measurements of glucose levels in a certain range, such as time in range (TIR), or glucose…”
Ndungu, M., Babalola, R. O., Brand, M., & Patel, R. S. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2078 · Cited by 5
“25 Meta-analyses, systematic reviews, and studies conducted outside the U.S. were excluded.”
Quah, P. L., Tan, L. K., Thain, S. P. T., Lek, N., Tagore, S., Chern, B. S. M., Ang, S. B., Wright, A., Jong, M., & Tan, K. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0700 · Cited by 3
“Posted online 2025 https://e-dmj.org tle glucose variations and chronic hyperglycemia [7,14] than the OGTT, which focuses on post-load glucose levels and can miss day-to-day fluctuations.”
Pan, Y., Gu, R., Li, Q., Wang, J., Zhang, Y., Zhao, L., Wu, Y., & Wei, L. S. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06994-y · Cited by 3
Öztop, N., Üzüm, A. K., Çelik, S. G., İdiz, C., Tütüncü, Y., Bağdemir, E., & Dınççağ, N. (2023) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.1193997 · Cited by 2
Mor, L., Toledano, E., Shoshan, N. B., Weiner, E., Paz, Y. G., Barda, G., & Levy, M. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07455-9 · Cited by 3
“First, the additive OGTT score mostly accentuates the extreme hyperglycemia rates but does not take into account impaired glucose variability between the four values which may impact maternal and neo-natal outcomes as well [23, 24].”
Glycemic variability in diagnosis of gestational diabetes as predictor of pharmacological treatment
Pardo, R. M., Baena-Nieto, M.-G., Córdoba-Doña, J. A., Cruzado-Begines, C., García-García-Doncel, L., Aguilar‐Diosdado, M., & Torres-Barea, I. M. (2024) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2024.03.010 · Cited by 3
Bernolian, N., Andonotopo, W., Bachnas, M. A., Prabowo, W., Yuliantara, E. E., Pramono, M. B. A., Dewantiningrum, J., Lukas, E., Sanjaya, I. N. H., Wiradnyana, A. A. G. P., et al. (2026) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_4_26 · Cited by 1
Chen, Y., Song, H., & Yang, M. (2026) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2026.2660439 · Cited by 1
Pardo, R. M., Baena-Nieto, M.-G., Córdoba-Doña, J. A., Cruzado-Begines, C., García-García-Doncel, L., Aguilar‐Diosdado, M., & Torres-Barea, I. M. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.12.007 · Cited by 1
Quah, P. L., Tan, K. H., Razali, N. S., & Razali, N. S. (2021) · doi:10.22541/au.163843479.99686909/v1
Clinical Characteristics of Mothers and Infants with Hyperglycemic Disorders in Pregnancy
Terada, H., & Nagano, N. (2023) · Journal of Nihon University Medical Association · doi:10.4264/numa.82.4_197
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602444
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602435
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602447
Filippo, D. D., Henry, A., Bell, C., Haynes, S., Chang, M. H. Y., Darling, J., & Welsh, A. (2024) · Figshare · doi:10.6084/m9.figshare.26575865
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602450
Filippo, D. D., Henry, A., Bell, C., Haynes, S., Chang, M. H. Y., Darling, J., & Welsh, A. (2024) · Figshare · doi:10.6084/m9.figshare.26575862
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602441
Filippo, D. D., Henry, A., Bell, C., Haynes, S., Chang, M. H. Y., Darling, J., & Welsh, A. (2024) · Figshare · doi:10.6084/m9.figshare.26575856
Filippo, D. D., Henry, A., Bell, C., Haynes, S., Chang, M. H. Y., Darling, J., & Welsh, A. (2024) · Figshare · doi:10.6084/m9.figshare.26575859
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602438
YAMAMORI, R., KUMAGAI, K., YAMADA, M., OSHIKA, A., NAGAI, A., TAKAGI, K., MURAKAMI, M., YAMAUCHI, K., SHIBATA, M., MIZUNO, T., et al. (2026) · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE · doi:10.2185/jjrm.74.497
Sleep Quality and Glycemic Variability Among Nondiabetic African American Pregnant Women
Irsheed, G. A., Genao, N., Siwakoti, L., Steffen, A. D., Ackerman, W. E., Quinn, L., Borbas, L., Alameda, G., Maganuru, R., Nazer, N., et al. (2026) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2026.08.001
Betatrophin Tertiles in the Understanding of Gestational Diabetes Mellitus: A Case–Control Approach
Cheralathan, K., Aishwarya, S., Vinodhini, V. M., Renuka, P., Anuradha, M., & Anjali, V. C. (2026) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-026-02450-3
Metadata
- Authors
- Yu, W., Wu, N., Li, L., OuYang, H., Qian, M., & Shen, H.
- Affiliations
- Sheng Jing Hospital (CN)
- Corresponding author
- Wu, Na
- Venue
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2020-08
- Volume
- Volume 13
- Pages
- 2729-2741
- ISSN
- 1178-7007 (ISSN-L)
- PMC
- PMC7414929
- OpenAlex
- W3047527842
- Semantic Scholar
- aea14f441afef259a01d7782c7be55260958a789
- Cited by
- 44
- References
- 67
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 11 · 2023: 13 · 2022: 11 · 2021: 3 · 2020: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Natural Science Foundation of China (LNSTNBYXYYFZXH-RS01B, 81700706)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- glycemic variability, gestational diabetes mellitus, HbA1c, glycemic control, adverse pregnancy outcomes, preeclampsia, cesarean section, macrosomia, neonatal outcomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.